Randomized multicenter Phase II trial of two different schedules of irinotecan combined with capecitabine as first‐line treatment in metastatic colorectal carcinoma

Emilio Bajetta, Roberto Buzzoni, Luigi Mariani et al.|Cancer|2004

Cited by 135